Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Echocardiography | 23 | 2026 | 1140 | 3.710 |
Why?
|
| Echocardiography, Three-Dimensional | 7 | 2024 | 62 | 3.170 |
Why?
|
| Heart Defects, Congenital | 10 | 2024 | 1908 | 1.730 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2024 | 252 | 1.460 |
Why?
|
| Heart Valve Prosthesis Implantation | 4 | 2026 | 440 | 1.040 |
Why?
|
| Tetralogy of Fallot | 2 | 2026 | 177 | 1.020 |
Why?
|
| Cardiac Catheterization | 5 | 2026 | 637 | 0.990 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2022 | 359 | 0.940 |
Why?
|
| Ductus Arteriosus | 1 | 2026 | 61 | 0.900 |
Why?
|
| Atrial Function, Left | 2 | 2025 | 36 | 0.860 |
Why?
|
| Tricuspid Valve | 1 | 2023 | 62 | 0.770 |
Why?
|
| Heart Valve Diseases | 1 | 2023 | 174 | 0.700 |
Why?
|
| Feasibility Studies | 2 | 2024 | 839 | 0.700 |
Why?
|
| Ultrasonography, Interventional | 1 | 2023 | 206 | 0.690 |
Why?
|
| Heart Transplantation | 2 | 2020 | 834 | 0.680 |
Why?
|
| Heart Ventricles | 5 | 2025 | 770 | 0.680 |
Why?
|
| Heart Valve Prosthesis | 4 | 2026 | 305 | 0.660 |
Why?
|
| Stroke Volume | 4 | 2025 | 532 | 0.630 |
Why?
|
| Pulmonary Valve Insufficiency | 3 | 2026 | 43 | 0.610 |
Why?
|
| Pediatrics | 4 | 2021 | 1243 | 0.600 |
Why?
|
| Pulmonary Valve | 3 | 2026 | 94 | 0.580 |
Why?
|
| Frailty | 1 | 2020 | 139 | 0.530 |
Why?
|
| Sinus of Valsalva | 1 | 2016 | 32 | 0.500 |
Why?
|
| Aortic Stenosis, Supravalvular | 1 | 2016 | 20 | 0.500 |
Why?
|
| Patient Care Bundles | 1 | 2016 | 24 | 0.490 |
Why?
|
| Heart Diseases | 1 | 2020 | 505 | 0.470 |
Why?
|
| Aortic Rupture | 1 | 2016 | 114 | 0.460 |
Why?
|
| Image Enhancement | 1 | 2016 | 173 | 0.460 |
Why?
|
| Quality Improvement | 2 | 2024 | 707 | 0.460 |
Why?
|
| Postoperative Care | 1 | 2016 | 303 | 0.430 |
Why?
|
| Exercise | 1 | 2020 | 869 | 0.420 |
Why?
|
| Child | 19 | 2025 | 26383 | 0.420 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 224 | 0.410 |
Why?
|
| Ventricular Function, Left | 5 | 2025 | 542 | 0.410 |
Why?
|
| Reproducibility of Results | 8 | 2025 | 2995 | 0.410 |
Why?
|
| Child, Preschool | 13 | 2025 | 15103 | 0.400 |
Why?
|
| Heart Failure | 2 | 2015 | 2318 | 0.360 |
Why?
|
| Heart Atria | 3 | 2025 | 338 | 0.360 |
Why?
|
| Humans | 36 | 2026 | 132194 | 0.350 |
Why?
|
| Adolescent | 12 | 2025 | 21021 | 0.330 |
Why?
|
| Cardiomyopathies | 1 | 2015 | 518 | 0.320 |
Why?
|
| Cardiac Surgical Procedures | 2 | 2016 | 1175 | 0.310 |
Why?
|
| Diastole | 3 | 2022 | 179 | 0.310 |
Why?
|
| Infant | 11 | 2025 | 13356 | 0.300 |
Why?
|
| Case-Control Studies | 4 | 2025 | 3461 | 0.300 |
Why?
|
| Observer Variation | 3 | 2025 | 319 | 0.280 |
Why?
|
| Levocardia | 1 | 2007 | 3 | 0.270 |
Why?
|
| Prosthesis Design | 3 | 2026 | 614 | 0.260 |
Why?
|
| Prospective Studies | 7 | 2026 | 6548 | 0.250 |
Why?
|
| Magnetic Resonance Imaging, Cine | 2 | 2025 | 174 | 0.250 |
Why?
|
| Hydrops Fetalis | 1 | 2007 | 84 | 0.250 |
Why?
|
| Atrioventricular Block | 1 | 2007 | 46 | 0.250 |
Why?
|
| Infant, Newborn | 8 | 2026 | 8615 | 0.250 |
Why?
|
| Recovery of Function | 2 | 2026 | 452 | 0.240 |
Why?
|
| Female | 17 | 2026 | 71459 | 0.220 |
Why?
|
| Systole | 2 | 2015 | 197 | 0.220 |
Why?
|
| Pericardial Effusion | 1 | 2025 | 72 | 0.220 |
Why?
|
| Heart | 3 | 2023 | 676 | 0.210 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2025 | 242 | 0.210 |
Why?
|
| Male | 15 | 2026 | 65494 | 0.210 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2025 | 163 | 0.210 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2026 | 1004 | 0.200 |
Why?
|
| Marfan Syndrome | 1 | 2024 | 147 | 0.190 |
Why?
|
| Bioprosthesis | 1 | 2023 | 112 | 0.180 |
Why?
|
| Gestational Age | 1 | 2026 | 1237 | 0.180 |
Why?
|
| Predictive Value of Tests | 2 | 2025 | 2325 | 0.170 |
Why?
|
| Sensitivity and Specificity | 2 | 2016 | 2144 | 0.170 |
Why?
|
| Accelerometry | 1 | 2020 | 66 | 0.160 |
Why?
|
| Sulfonamides | 1 | 2022 | 297 | 0.160 |
Why?
|
| Age Factors | 2 | 2025 | 2869 | 0.160 |
Why?
|
| Hypertension, Pulmonary | 1 | 2025 | 465 | 0.160 |
Why?
|
| Diagnostic Errors | 2 | 2024 | 344 | 0.160 |
Why?
|
| Treatment Outcome | 5 | 2026 | 13022 | 0.160 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 78 | 0.150 |
Why?
|
| Atrial Appendage | 1 | 2020 | 76 | 0.150 |
Why?
|
| Artificial Intelligence | 1 | 2024 | 333 | 0.150 |
Why?
|
| Reference Values | 2 | 2022 | 693 | 0.140 |
Why?
|
| Disease Progression | 1 | 2024 | 2230 | 0.140 |
Why?
|
| Hemodynamics | 3 | 2026 | 819 | 0.130 |
Why?
|
| Missouri | 1 | 2016 | 41 | 0.130 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 80 | 0.130 |
Why?
|
| Boston | 1 | 2016 | 118 | 0.120 |
Why?
|
| Retrospective Studies | 5 | 2026 | 17772 | 0.120 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2025 | 1270 | 0.120 |
Why?
|
| Pregnancy | 2 | 2026 | 7604 | 0.120 |
Why?
|
| Heart-Assist Devices | 1 | 2025 | 999 | 0.120 |
Why?
|
| Vascular Stiffness | 1 | 2016 | 83 | 0.120 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2015 | 80 | 0.110 |
Why?
|
| Regression Analysis | 1 | 2015 | 772 | 0.100 |
Why?
|
| Quality Indicators, Health Care | 1 | 2015 | 237 | 0.100 |
Why?
|
| Graft Rejection | 1 | 2015 | 564 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1476 | 0.080 |
Why?
|
| Myocardium | 1 | 2015 | 875 | 0.080 |
Why?
|
| Phenotype | 1 | 2020 | 4550 | 0.080 |
Why?
|
| Quality of Life | 1 | 2020 | 2117 | 0.080 |
Why?
|
| Neoplasms | 1 | 2023 | 2968 | 0.070 |
Why?
|
| United States | 4 | 2026 | 11867 | 0.070 |
Why?
|
| Epoprostenol | 1 | 2007 | 42 | 0.070 |
Why?
|
| Pulmonary Surfactants | 1 | 2007 | 45 | 0.070 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2007 | 41 | 0.070 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2007 | 78 | 0.060 |
Why?
|
| Severity of Illness Index | 1 | 2015 | 3098 | 0.060 |
Why?
|
| Persistent Fetal Circulation Syndrome | 1 | 2007 | 84 | 0.060 |
Why?
|
| Young Adult | 3 | 2025 | 10131 | 0.060 |
Why?
|
| Risk Factors | 3 | 2026 | 11041 | 0.060 |
Why?
|
| Fatal Outcome | 1 | 2007 | 364 | 0.060 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 5284 | 0.060 |
Why?
|
| Risk Assessment | 1 | 2015 | 3721 | 0.060 |
Why?
|
| Prognosis | 1 | 2015 | 4965 | 0.060 |
Why?
|
| Time Factors | 2 | 2026 | 6289 | 0.060 |
Why?
|
| Balloon Valvuloplasty | 1 | 2024 | 25 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2007 | 422 | 0.050 |
Why?
|
| Mitral Valve Prolapse | 1 | 2024 | 36 | 0.050 |
Why?
|
| Ventricular Function, Right | 1 | 2025 | 126 | 0.050 |
Why?
|
| Syndrome | 1 | 2007 | 1170 | 0.050 |
Why?
|
| Cardiac Imaging Techniques | 1 | 2024 | 28 | 0.050 |
Why?
|
| Europe | 1 | 2024 | 373 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2002 | 8 | 0.050 |
Why?
|
| Lorazepam | 1 | 2002 | 12 | 0.050 |
Why?
|
| Multimodal Imaging | 1 | 2023 | 114 | 0.050 |
Why?
|
| Mitral Valve | 1 | 2024 | 250 | 0.050 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2024 | 184 | 0.050 |
Why?
|
| Data Collection | 1 | 2023 | 372 | 0.040 |
Why?
|
| Hypnotics and Sedatives | 1 | 2002 | 132 | 0.040 |
Why?
|
| Consensus | 1 | 2024 | 530 | 0.040 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2020 | 116 | 0.040 |
Why?
|
| Allied Health Personnel | 1 | 2021 | 74 | 0.040 |
Why?
|
| Hospital Costs | 1 | 2020 | 180 | 0.040 |
Why?
|
| Pyrimidines | 1 | 2022 | 452 | 0.040 |
Why?
|
| Registries | 1 | 2026 | 1602 | 0.040 |
Why?
|
| Incidence | 1 | 2025 | 3358 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2024 | 1307 | 0.030 |
Why?
|
| Texas | 1 | 2025 | 3657 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2020 | 801 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 5127 | 0.030 |
Why?
|
| Length of Stay | 1 | 2020 | 1404 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 28963 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3939 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 31771 | 0.020 |
Why?
|
| Stimulation, Chemical | 1 | 2007 | 43 | 0.020 |
Why?
|
| Intermittent Positive-Pressure Ventilation | 1 | 2007 | 9 | 0.020 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2007 | 47 | 0.020 |
Why?
|
| Foramen Ovale, Patent | 1 | 2007 | 13 | 0.020 |
Why?
|
| High-Frequency Ventilation | 1 | 2007 | 19 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2007 | 192 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2007 | 167 | 0.020 |
Why?
|
| Hypoxia | 1 | 2007 | 246 | 0.010 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2007 | 146 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 2002 | 148 | 0.010 |
Why?
|
| Lactic Acid | 1 | 2002 | 148 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 550 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2002 | 956 | 0.010 |
Why?
|